This study examined the effectiveness of plasma NGAL (pNGAL) as biomarker for CKD and AKI prediction in an emergency department (ED) setting and for predicting the presence of CKD and AKI in future admissions (readmission). The gene discussed is LCN2; the disease is acute kidney injury.